Related Experiment Video
Updated: Mar 20, 2026

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells
Published on: January 12, 2020
Transcription Factor NF-κB: An Update on Intervention Strategies
Arvind Panday1,2, Maria Eugenia Inda3, Prathyusha Bagam4
1Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA, 70803, USA.
Nuclear factor kappa B (NF-κB) regulates key cellular processes. This review details NF-κB's role in DNA repair and diseases like cancer, offering insights into therapeutic strategies.
Area of Science:
- Molecular Biology
- Immunology
- Cell Biology
Background:
- Nuclear factor kappa B (NF-κB) is a crucial transcription factor family regulating over 150 genes.
- NF-κB controls fundamental cellular processes including inflammation, immunity, proliferation, differentiation, and survival.
- Chronic activation or dysregulation of NF-κB signaling is implicated in the pathogenesis of numerous diseases.
Purpose of the Study:
- To provide an updated review on the role of NF-κB in DNA repair.
- To explore the involvement of NF-κB in various diseases, including cardiovascular diseases, HIV, asthma, herpes simplex virus infection, COPD, and cancer.
- To discuss targeted inhibitors and future therapeutic strategies for NF-κB-related conditions.
Main Methods:
- Literature review and synthesis of existing research on NF-κB.
- Analysis of NF-κB's function in DNA repair mechanisms.
- Examination of NF-κB's role in the pathogenesis of specific diseases.
Main Results:
- NF-κB plays a significant role in DNA repair pathways.
- Dysregulated NF-κB signaling is a common factor in the development and progression of diverse diseases.
- Specific molecular targets for NF-κB inhibition have been identified.
Conclusions:
- Understanding the NF-κB pathway is critical for developing effective treatments for a wide range of diseases.
- Targeting NF-κB offers a promising therapeutic avenue for inflammatory, immune-related, and oncogenic conditions.
- Further research into selective NF-κB inhibitors and therapeutic strategies is warranted.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
NF-kB-dependent Signaling Pathway
Co-activators and Co-repressors
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Transcription Factors
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:

